Herombopag Olamine in the Treatment of Thrombocytopenia After Chemotherapy

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
To evaluate the efficacy and safety of hetrombopag in the treatment of thrombocytopenia after chemotherapy in patients with digestive system malignant tumors
Epistemonikos ID: 4132b537c914f558ce122ec50d3845cdc3bcf015
First added on: May 14, 2024